201 related articles for article (PubMed ID: 19104401)
1. Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept.
Faradji RN; Tharavanij T; Messinger S; Froud T; Pileggi A; Monroy K; Mineo D; Baidal DA; Cure P; Ponte G; Mendez AJ; Selvaggi G; Ricordi C; Alejandro R
Transplantation; 2008 Dec; 86(12):1658-65. PubMed ID: 19104401
[TBL] [Abstract][Full Text] [Related]
2. Supplemental islet infusions restore insulin independence after graft dysfunction in islet transplant recipients.
Koh A; Imes S; Kin T; Dinyari P; Malcolm A; Toso C; Shapiro AM; Senior P
Transplantation; 2010 Feb; 89(3):361-5. PubMed ID: 20145529
[TBL] [Abstract][Full Text] [Related]
3. The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects.
Froud T; Faradji RN; Pileggi A; Messinger S; Baidal DA; Ponte GM; Cure PE; Monroy K; Mendez A; Selvaggi G; Ricordi C; Alejandro R
Transplantation; 2008 Jul; 86(1):36-45. PubMed ID: 18622276
[TBL] [Abstract][Full Text] [Related]
4. G-CSF and Exenatide Might Be Associated with Increased Long-Term Survival of Allogeneic Pancreatic Islet Grafts.
Zoso A; Serafini P; Lanzoni G; Peixoto E; Messinger S; Mantero A; Padilla-Téllez ND; Baidal DA; Alejandro R; Ricordi C; Inverardi L
PLoS One; 2016; 11(6):e0157245. PubMed ID: 27285580
[TBL] [Abstract][Full Text] [Related]
5. Islet transplantation for brittle type 1 diabetes: the UIC protocol.
Gangemi A; Salehi P; Hatipoglu B; Martellotto J; Barbaro B; Kuechle JB; Qi M; Wang Y; Pallan P; Owens C; Bui J; West D; Kaplan B; Benedetti E; Oberholzer J
Am J Transplant; 2008 Jun; 8(6):1250-61. PubMed ID: 18444920
[TBL] [Abstract][Full Text] [Related]
6. Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction.
Faradji RN; Froud T; Messinger S; Monroy K; Pileggi A; Mineo D; Tharavanij T; Mendez AJ; Ricordi C; Alejandro R
Cell Transplant; 2009; 18(10):1247-59. PubMed ID: 20003758
[TBL] [Abstract][Full Text] [Related]
7. Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes.
Froud T; Baidal DA; Faradji R; Cure P; Mineo D; Selvaggi G; Kenyon NS; Ricordi C; Alejandro R
Transplantation; 2008 Dec; 86(12):1695-701. PubMed ID: 19104407
[TBL] [Abstract][Full Text] [Related]
8. Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes.
Ghofaili KA; Fung M; Ao Z; Meloche M; Shapiro RJ; Warnock GL; Elahi D; Meneilly GS; Thompson DM
Transplantation; 2007 Jan; 83(1):24-8. PubMed ID: 17220786
[TBL] [Abstract][Full Text] [Related]
9. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience.
Froud T; Ricordi C; Baidal DA; Hafiz MM; Ponte G; Cure P; Pileggi A; Poggioli R; Ichii H; Khan A; Ferreira JV; Pugliese A; Esquenazi VV; Kenyon NS; Alejandro R
Am J Transplant; 2005 Aug; 5(8):2037-46. PubMed ID: 15996257
[TBL] [Abstract][Full Text] [Related]
10. Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes.
Bellin MD; Kandaswamy R; Parkey J; Zhang HJ; Liu B; Ihm SH; Ansite JD; Witson J; Bansal-Pakala P; Balamurugan AN; Papas KK; Sutherland DE; Moran A; Hering BJ
Am J Transplant; 2008 Nov; 8(11):2463-70. PubMed ID: 18808408
[TBL] [Abstract][Full Text] [Related]
11. The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.
Sahraoui A; Winzell MS; Gorman T; Smith DM; Skrtic S; Hoeyem M; Abadpour S; Johansson L; Korsgren O; Foss A; Scholz H
PLoS One; 2015; 10(3):e0121204. PubMed ID: 25793295
[TBL] [Abstract][Full Text] [Related]
12. Effect of exenatide on gastric emptying and graft survival in islet allograft recipients.
Peixoto EM; Froud T; Gomes LS; Zavala LM; Corrales A; Herrada E; Ricordi C; Alejandro R
Transplant Proc; 2011 Nov; 43(9):3231-4. PubMed ID: 22099764
[TBL] [Abstract][Full Text] [Related]
13. International trial of the Edmonton protocol for islet transplantation.
Shapiro AM; Ricordi C; Hering BJ; Auchincloss H; Lindblad R; Robertson RP; Secchi A; Brendel MD; Berney T; Brennan DC; Cagliero E; Alejandro R; Ryan EA; DiMercurio B; Morel P; Polonsky KS; Reems JA; Bretzel RG; Bertuzzi F; Froud T; Kandaswamy R; Sutherland DE; Eisenbarth G; Segal M; Preiksaitis J; Korbutt GS; Barton FB; Viviano L; Seyfert-Margolis V; Bluestone J; Lakey JR
N Engl J Med; 2006 Sep; 355(13):1318-30. PubMed ID: 17005949
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.
Ryan EA; Lakey JR; Rajotte RV; Korbutt GS; Kin T; Imes S; Rabinovitch A; Elliott JF; Bigam D; Kneteman NM; Warnock GL; Larsen I; Shapiro AM
Diabetes; 2001 Apr; 50(4):710-9. PubMed ID: 11289033
[TBL] [Abstract][Full Text] [Related]
15. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
Shapiro AM; Lakey JR; Ryan EA; Korbutt GS; Toth E; Warnock GL; Kneteman NM; Rajotte RV
N Engl J Med; 2000 Jul; 343(4):230-8. PubMed ID: 10911004
[TBL] [Abstract][Full Text] [Related]
16. Sustained Islet Allograft Function After Peritransplant Treatment Using Exenatide With and Without Everolimus.
Bertuzzi F; Marazzi M; De Carlis LG; Rampoldi AG; Bonomo M; Antonioli B; Tosca MC; Galuzzi M; De Gasperi A; Colussi G
Transplantation; 2016 Nov; 100(11):e117-e118. PubMed ID: 27517727
[No Abstract] [Full Text] [Related]
17. Primary graft function, metabolic control, and graft survival after islet transplantation.
Vantyghem MC; Kerr-Conte J; Arnalsteen L; Sergent G; Defrance F; Gmyr V; Declerck N; Raverdy V; Vandewalle B; Pigny P; Noel C; Pattou F
Diabetes Care; 2009 Aug; 32(8):1473-8. PubMed ID: 19638525
[TBL] [Abstract][Full Text] [Related]
18. Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes.
Rother KI; Spain LM; Wesley RA; Digon BJ; Baron A; Chen K; Nelson P; Dosch HM; Palmer JP; Brooks-Worrell B; Ring M; Harlan DM
Diabetes Care; 2009 Dec; 32(12):2251-7. PubMed ID: 19808924
[TBL] [Abstract][Full Text] [Related]
19. Successful islet transplantation: continued insulin reserve provides long-term glycemic control.
Ryan EA; Lakey JR; Paty BW; Imes S; Korbutt GS; Kneteman NM; Bigam D; Rajotte RV; Shapiro AM
Diabetes; 2002 Jul; 51(7):2148-57. PubMed ID: 12086945
[TBL] [Abstract][Full Text] [Related]
20. Early metabolic markers of islet allograft dysfunction.
Baidal DA; Faradji RN; Messinger S; Froud T; Monroy K; Ricordi C; Alejandro R
Transplantation; 2009 Mar; 87(5):689-97. PubMed ID: 19295313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
